Lonza Group Overview

  • Founded
  • 1897
Founded
  • Status
  • Public
  • Employees
  • 14,405
Employees
  • Stock Symbol
  • LONN
Stock Symbol
  • Investments
  • 38
  • Share Price
  • $748.83
  • (As of Wednesday Closing)

Lonza Group General Information

Description

Lonza Group is a contract development and manufacturing organization. It also produces microbicides and other chemicals for personal care, health and hygiene, agrochemical, and industrial preservation markets. The firm is organized into two segments: Pharma Biotech and Nutrition, which encompasses drug development and manufacturing as well as consumer health manufacturing, and Specialty Ingredients, which encompasses businesses in industrials, consumer care, and agriculture. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic and government research organizations, and consumer goods and industrial companies.

Contact Information

Website
www.lonza.com
Formerly Known As
Lonza AG Electricity Works
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Specialty Chemicals
Stock Exchange
SWX
Primary Office
  • Muenchensteinerstrasse 38
  • 4002 Basel
  • Switzerland
+41 061 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lonza Group Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$748.83 $745.55 $547.99 - $769.97 $55.4B 74.3M 181K $10.49

Lonza Group Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 56,771,843 51,841,178 30,589,235 22,996,261
Revenue 5,280,793 4,800,801 4,233,630 5,663,192
EBITDA 752,516 1,487,737 1,329,362 1,461,271
Net Income 781,078 925,443 649,083 571,224
Total Assets 16,461,634 16,515,200 14,284,830 14,139,598
Total Debt 3,959,869 4,365,443 3,905,339 4,125,785
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lonza Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lonza Group‘s full profile, request access.

Request a free trial

Lonza Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Lonza Group is a contract development and manufacturing organization. It also produces microbicides and other chemicals
Biotechnology
Basel, Switzerland
14,405 As of 2021
00000
0.000 0000-00-00
00000000000 00000

00000000

ipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim v
0000000000000
Saint Louis, MO
00000 As of 0000
000 0000-00-00
000000&0

000000 0

r in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
000000000000000
Plankstadt, Germany
000 As of 0000
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lonza Group Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MilliporeSigma Corporate Backed or Acquired Saint Louis, MO 00000 000000&0
000000 000000 Venture Capital-Backed Plankstadt, Germany 000 00000 00000
00000 000000000000 Corporate Backed or Acquired Goole, United Kingdom 0000 00000 000000000 00000
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
0000000 Private Equity-Backed Beuvry-la-Forêt, France 00 0000 000000000000 0000
You’re viewing 5 of 10 competitors. Get the full list »

Lonza Group Executive Team (34)

Name Title Board Seat Contact Info
Pierre-Alain Ruffieux Chief Executive Officer
Rodolfo Savitzky Chief Financial Officer and Member of the Executive Committee
Stefan Stoffel Chief Operating Officer, Pharma & Biotech Segment & Member of the Executive Committee
Caroline Barth Chief Human Resources Officer & Member of the Executive Committee
Jean-Emile Zanetto Ph.D Head of Strategy & Corporate Development Director - Lonza
You’re viewing 5 of 34 executive team members. Get the full list »

Lonza Group Board Members (8)

Name Representing Role Since
000000 000000 Lonza Group Chairman of the Board of Directors & Independent member of the Board of Directors 000 0000
00000000 00000 Lonza Group Chief Human Resources Officer & Member of the Executive Committee 000 0000
0000000 00000000 Lonza Group Chief Financial Officer and Member of the Executive Committee 000 0000
000000 0000000 Lonza Group Chief Operating Officer, Pharma & Biotech Segment & Member of the Executive Committee 000 0000
You’re viewing 4 of 8 board members. Get the full list »

Lonza Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lonza Group Investments & Acquisitions (38)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 30-Apr-2021 00000 00000 00 00000 Drug Discovery
0000000 0000000000 12-Mar-2020 00000 00000 00 0000 Drug Discovery
00000000 02-Sep-2019 00000 0000000 Therapeutic Devices 0000 0000
00 0000000000 (000 10-Dec-2018 000000000 00000 00 Buildings and Property
Octane Biotech 31-Oct-2018 Merger/Acquisition 0000 Biotechnology 0000 0000
You’re viewing 5 of 38 investments and acquisitions. Get the full list »

Lonza Group Subsidiaries (9)

Company Name Industry Location Founded
Vivante GMP Solutions Other Pharmaceuticals and Biotechnology Houston, TX 2009
000000 0000000 Biotechnology Kingston, Canada 0000
00000000000 0000 0 Clinics/Outpatient Services Tallinn, Estonia 0000
000000 Biotechnology Münster, Germany 0000
00000 Biotechnology Cologne, Germany 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

Lonza Group Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 13-Nov-2017 0000 00000 00.000 Completed
  • 5 buyers
0000000000000 02-Dec-2016 00000 00000 00 000 Completed
  • 4 buyers
0000000 00000 14-Feb-2013 00000 00000 00 00.00 Completed
  • 3 buyers
0000000 00000 17-Mar-2010 00000 00000 00 00.00 Completed
  • 00000 00000
Lonza (peptides business in Belgium) 17-Jan-2006 Merger/Acquisition 00000 Completed
To view Lonza Group’s complete exits history, request access »